These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7302907)

  • 1. Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assays.
    Hurst RE; van Dedem G; Settine JM
    Thromb Res; 1981 Jun 1-25; 22(5-6):633-43. PubMed ID: 7302907
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
    Teien AN; Abildgaard U; Höök M; Lindahl U
    Thromb Res; 1977 Aug; 11(2):107-17. PubMed ID: 905965
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of the anticoagulant action of heparin.
    Björk I; Lindahl U
    Mol Cell Biochem; 1982 Oct; 48(3):161-82. PubMed ID: 6757715
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.
    Lane DA; MacGregor IR; VanRoss M; Cella G; Kakkar VV
    Thromb Res; 1979; 16(5-6):651-62. PubMed ID: 524315
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Sims GE
    Thromb Res; 1976 Dec; 9(6):575-83. PubMed ID: 1006626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current data on heparin].
    Choay J
    Agressologie; 1983 Nov; 24(10):491-4. PubMed ID: 6367508
    [No Abstract]   [Full Text] [Related]  

  • 9. Fractionated tritium-labelled heparin studied in vitro and in vivo.
    Shanberge JN; Gruhl M; Kitani T; Ambegaonkar S; Kambayashi J; Nakagawa M; Lenter D
    Thromb Res; 1978 Nov; 13(5):767-83. PubMed ID: 741450
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement inhibitory and anticoagulant activities of fractionated heparins.
    Hennink WE; Klerx JP; van Dijk H; Feijen J
    Thromb Res; 1984 Nov; 36(4):281-92. PubMed ID: 6523441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low molecular weight heparin compared with unfractionated heparin.
    Thomas DP; Merton RE
    Thromb Res; 1982 Nov; 28(3):343-50. PubMed ID: 7179221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J
    Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low molecular weight heparins].
    Kher A; Bara L; Samama M
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular weight determination of commercial heparin sodium USP and its sterile solutions.
    Rodriguez HJ; Vanderwielen AJ
    J Pharm Sci; 1979 May; 68(5):588-91. PubMed ID: 571022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-activity heparin: chain length, affinity for antithrombin, and anticoagulant activity.
    Radoff S; Danishefsky I
    Arch Biochem Biophys; 1982 Apr; 215(1):163-70. PubMed ID: 7092223
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins.
    Lane DA; Ryan K
    J Lab Clin Med; 1990 Aug; 116(2):269-70. PubMed ID: 2394942
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Choay domain -- the structure responsible for the anticoagulant action of heparins].
    Hemker HC; al Dieri R; Wagenvoord R; Béguin S
    Bull Acad Natl Med; 2003; 187(1):59-66; discussion 66-7. PubMed ID: 14556454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of thrombin-receptors of thrombocytes for the interaction of heparins and low-molecular-weight heparin in human whole blood clotting.
    Harenberg J; Schuler M; Zimmermann R; Heptner W
    Haemostasis; 1988; 18 Suppl 3():20-2. PubMed ID: 2840370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.